Article Details

Acute Myeloid Leukemia Pipeline Insight 2025: Akeso's FDA ODD for Ligufalimab, 100+ ...

Retrieved on: 2025-09-16 23:20:04

Tags for this article:

Click the tags to see associated articles and topics

Acute Myeloid Leukemia Pipeline Insight 2025: Akeso's FDA ODD for Ligufalimab, 100+ .... View article details on hiswai:

Excerpt

Immuno-oncology approaches—including monoclonal antibodies, bispecific T-cell engagers, and antibody-drug conjugates—are emerging as cornerstones ...

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo